Daniel J. George
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 85
- Renal cell carcinoma treatment 81
- Prostate Cancer Diagnosis and Treatment 17
- Oncology 77
- Cancer Immunotherapy and Biomarkers 37
- Co-authors
- Philip W. Kantoff (28 shared papers)Susan Halabi (27 shared papers)Eric J. Small (16 shared papers)M. Dror Michaelson (13 shared papers)Andrew J. Armstrong (52 shared papers)Mario A. Eisenberger (4 shared papers)William Oh (17 shared papers)Michael R. Harrison (33 shared papers)
- Journals
- Journal of Clinical Oncology (81 papers)Clinical Cancer Research (16 papers)Annals of Oncology (11 papers)Clinical Genitourinary Cancer (11 papers)Cancer (8 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Daniel J. George
252 papers receiving 8.0k citations
Daniel J. George's Hit Papers
Peers
Comparison fields: 5 of 125
- Pulmonary and Respiratory Medicine 4.1k
- Cancer Research 1.4k
- Oncology 2.1k
- Molecular Biology 2.7k
- Radiology, Nuclear Medicine and Imaging 630
Countries citing papers authored by Daniel J. George
This map shows the geographic impact of Daniel J. George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. George more than expected).
Fields of papers citing papers by Daniel J. George
This network shows the impact of papers produced by Daniel J. George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. George. The network helps show where Daniel J. George may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel J. George, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 258 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial Hit paper breakdown → | 2017 | 512 |
| 2 | 1995 | 488 | |
| 3 | Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update Hit paper breakdown → | 2018 | 272 |
| 4 | 2008 | 247 | |
| 5 | 2003 | 227 | |
| 6 | Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480. | 2001 | 212 |
| 7 | 2004 | 205 | |
| 8 | 2019 | 186 | |
| 9 | A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial Hit paper breakdown → | 2021 | 176 |
| 10 | 2014 | 168 | |
| 11 | 2001 | 154 | |
| 12 | 2005 | 144 | |
| 13 | 2018 | 134 | |
| 14 | 2012 | 124 | |
| 15 | 2020 | 123 | |
| 16 | 2022 | 121 | |
| 17 | 2010 | 113 | |
| 18 | 2004 | 109 | |
| 19 | 2009 | 106 | |
| 20 | Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555). | 1999 | 103 |
About Daniel J. George
Daniel J. George is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 258 papers that have together received 8.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (85 papers), Renal cell carcinoma treatment (81 papers), Cancer Genomics and Diagnostics (37 papers), Cancer Immunotherapy and Biomarkers (37 papers), Radiopharmaceutical Chemistry and Applications (25 papers), Renal and related cancers (24 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Bladder and Urothelial Cancer Treatments (16 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.1k citations), Cancer Research (1.4k citations), Oncology (2.1k citations), Molecular Biology (2.7k citations) and Radiology, Nuclear Medicine and Imaging (630 citations). Daniel J. George has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Philip W. Kantoff, Susan Halabi, Eric J. Small, M. Dror Michaelson, Andrew J. Armstrong, Mario A. Eisenberger, William Oh, Michael R. Harrison, Michael J. Morris and Tian Zhang. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology, Clinical Genitourinary Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.